María Otaola

Statistics

Publications

Citations

1.2K

H-Index

Active since

2013

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Università Cattolica del Sacro Cuore

National Jewish Health

University of Colorado Denver

University of Michigan

María Otaola is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, interstitial lung disease, and pharmacotherapy.

ORCID

Publications per year

2013–2024

Publications

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

Anna L. Peljto, Rachel Z. Blumhagen, Avram Walts et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 80 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

Vincent Cottin, Luca Richeldi, Iván O. Rosas et al. · Respiratory Research · 2021 · 70 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

Sujal R. Desai, Nishanth Sivarasan, Kerri A. Johannson et al. · The Lancet Respiratory Medicine · 2023 · 67 citations · Full text

Medicine, Pathology, Radiology +13

1–5 of 8